Skip to content
Subscriber Only

U.S. Ends Pause on J&J’s Vaccine After Concern About Clots

  • Shot is safe and effective and risks of clots is ‘very low’
  • Move follows advisory vote recommending that shots resume
Vaccine-Givers Race Time at an Atlantic City Convention Hall
Photographer: Mark Kauzlarich/Bloomberg
Updated on

U.S. health agencies lifted the pause on Johnson & Johnson’s Covid-19 vaccine on Friday, 10 days after urging providers to hold off on using the shot while they reviewed serious and rare cases of blood clots among several people who received it.

The Food and Drug Administration and the Centers for Disease Control and Prevention said in a statement that they have determined that the pause that was put in place on April 13 should end and that use of the vaccine should resume. Inoculations can begin immediately, CDC Director Rochelle Walensky said in a briefing.